A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

191

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 25, 2022

Study Completion Date

October 27, 2022

Conditions
Non-Hodgkin LymphomaFollicular Lymphoma
Interventions
DRUG

10 MBq/kg Betalutin

DRUG

15 MBq/kg Betalutin

DRUG

20 MBq/kg Betalutin

DRUG

40 mg lilotomab

DRUG

100 mg/m2 lilotomab

DRUG

60 mg/m2 lilotomab

DRUG

Rituximab

DRUG

12.5 mBq/kg Betalutin

Trial Locations (96)

1090

Medizinische Universität Wien - AKH Wien, Universitaetsklinik fuer Innere Medizin I, Vienna

3000

UZ Leuven, Leuven

6020

Medizinische Universitaet Innsbruck, Innsbruck

7000

Royal Hobart Hospital, Hobart

7006

St Olav Hospital, Trondheim

9000

Universitair Ziekenhuis Gent (UZ Gent), Ghent

11794

Stony Brook University Medical Center, Stony Brook

15224

West Penn Hospital, Pittsburgh

15232

University of Pittsburgh Medical Center, Pittsburgh

19104

University of Pennsylvania, Philadelphia

27710

Duke University Medical Center, Durham

33486

Boca Raton Regional Hospital, Boca Raton

40138

"Istituto di Ematologia ed Oncologia Medica L. & A. Seragnoli-Policlinico S. Orsola Malpighi", Bologna

40207

Norton Cancer Institute, Louisville

46020

Health Research Institute La Fe - Hospital La Fe, Valencia

46026

Hospital Universitario Doctor Peset, Valencia

50134

Universita Degli Studi Di Firenze-Azienda Ospedaliero-Universitaria Careggi (AOUC), Florence

60153

Loyola University Medical Center, Maywood

70121

Ochsner Clinic Foundation, New Orleans

72205

University Of Arkansas For Medical Sciences, Little Rock

75010

Hôpital Saint Louis, Paris

75013

AP-HP La Pitié salpétrière, Paris

75246

Baylor College of Medicine, Dallas

90813

Pacific Shores Medical Group, Long Beach

94143

University of California, San Francisco (UCSF), San Francisco

97239

Oregon Health & Science University, Portland

Unknown

CH Jolimont, La Louvière

Helsinki University Hospital Comprehensive Cancer Center, Helsinki

Central Hospital Of Central Finland, Jyväskylä

Institut Bergonie, Bordeaux

Chu Grenoble - Hopital Michallon, Grenoble

Centre Hospitalier Lyon Sud, Pierre-Bénite

Centre Hospitalier Regional Universitaire de Tours (CHRU de Tours) - Hopital Bretonneau, Tours

Orszagos Onkologiai Intezet, A-Belgyogyaszati Onkologiai Osztaly, Budapest

Semmelweis Egyetem, I Belgyogyaszati Klinika, Hematologiai Osztaly, Budapest

Mater Misericordiae University Hospital, Dublin

St James's Hospital, Dublin

University Hospital Galway, Galway

Haemek Medical Center, Afula

Asaf Harofeh Medical Center, Be’er Ya‘aqov

Bnai Zion Medical Center (BZMC), Haifa

Rambam Health Care Campus (RHCC), Haifa

יHadassah Ein Karem Medical Center, Jerusalem

Sourasky Medical Center, Tel Aviv

SS Antonio & Biagio and C. Arrigo Hospital, Alessandria

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola

Istituto Europeo di Oncologia (IEO), Milan

"Istituto Nazionale Tumori Fondazione G. Pascale", Napoli

Azienda Ospedaliera Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia

AO Ordine Mauriziano di Torino, Torino

University Medical Center Groningen, Groningen

Haukeland Universitetssjukehus, Bergen

Szpital Morski Im.Pck W Gdynia, Gdynia

National University Hospital, Singapore

Chonbuk National University Hospital, Jeonju

Samsung Medical Center, Seoul

Ulsan University Hospital, Ulsan

Corporacio Sanitaria Parc Taulí, Barcelona

Hospital Universitario Puerta del Mar, Cadiz

Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda

Complexo Hospitalario Universitario de Ourense, Ourense

Clinica Universidad De Navarra, Pamplona

Hospital Clinico Universitario de Salamanca, Salamanca

Hospital Universitario Virgen Macarena, Seville

Cancercentrum -Center of Oncology, Umeå

Kantonsspital Graubünden, Chur

Cukurova Universitesi Tip Fakültesi, Ic Hastaliklari Anabilim Dali, Adana

Ankara Onkoloji Egitim ve Arastirma Hastanesi, Ankara

Ankara Universitesi Tip Fakultesi Cebeci Hastanesi Ic, Ankara

Hacettepe University Oncology Hospital, Ankara

Eskisehir Osmangazi Universitesi Tip Fakultesi Ic Hastaliklar, Eskişehir

Istanbul Universitesi Istanbul Tip Fakultesi, Fatih

Ege Universitesi Tip Fakültesi, Izmir

Celal Bayar Universitesi Tip Fakultesi, Manisa

Ondokuz Mayis Universitesi, Samsun

Gaziantep Universitesi Sahinbey Arastirma ve Uygulama, Şehitkamil

Western General Hospital, Edinburgh

University College London Hospitals Nhs Foundation Trust, London

Derriford Hospital, Plymouth

The Royal Marsden NHS Foundation Trust, Sutton

N6A 5W9

London Health Sciences Centre, London

P6B 0A8

Sault Area Hospital, Sault Ste. Marie

M5G 2M

Princes Margaret Cancer Centre, Toronto

10 000

Clinical Hospital Centre Zagreb, Zagreb

779 00

University Hospital Olomouc, Olomouc

708 52

FNsP Ostrava, Ostrava-Poruba

DK-8000

Aarhus Universitetshospital, Aarhus

DK-5000

Odense Univerisity Hospital, Odense

0310

The Norwegian Radium Hospital, Oslo

50-510

Pratia MCM Kraków, Krakow

02-097

Centrum Onkologii, Warsaw

BH15 2JB

Dorset Cancer Centre Poole Hospital, Poole

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

G12 0YN

Beatson West of Scotland Cancer Centre, Glasgow

W12 0HS

Imperial College Healthcare NHS Trust, Hammersmith Hospital, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

ICON Clinical Research

INDUSTRY

lead

Nordic Nanovector

INDUSTRY